Emergence of antimicrobial resistance among Pseudomonas aeruginosa: implications for therapy
JP Lynch III, GG Zhanel… - Seminars in respiratory and …, 2017 - thieme-connect.com
Pseudomonas aeruginosa (PA), a nonlactose fermenting gram-negative bacillus, is a
common cause of nosocomial infections in critically ill or debilitated patients, particularly …
common cause of nosocomial infections in critically ill or debilitated patients, particularly …
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three …
M Meschiari, I Franconi, E Bacca, V Bianco, G Orlando… - Infection, 2021 - Springer
Purpose Post-neurosurgical infection caused by extensively drug resistant Pseudomonas
aeruginosa (XDR-PA) are becoming a matter of great concern due to limited therapeutic …
aeruginosa (XDR-PA) are becoming a matter of great concern due to limited therapeutic …
Pseudomonas aeruginosa pneumonia: evolution of antimicrobial resistance and implications for therapy
JP Lynch III, GG Zhanel - Seminars in Respiratory and Critical …, 2022 - thieme-connect.com
Pseudomonas aeruginosa (PA), a non–lactose-fermenting gram-negative bacillus, is a
common cause of nosocomial infections in critically ill or debilitated patients, particularly …
common cause of nosocomial infections in critically ill or debilitated patients, particularly …
Intermittent Short-term infusion vs. Continuous infusion of piperacillin: steady state concentrations in porcine cervical spine tissue evaluated by microdialysis
EK Petersen, P Hanberg, M Knudsen, SK Tøstesen… - Antibiotics, 2022 - mdpi.com
Background: Piperacillin is a central drug in the treatment of Pseudomonas aeruginosa
spondylodiscitis. Intermittent short-term infusion (STI) remains standard treatment in most …
spondylodiscitis. Intermittent short-term infusion (STI) remains standard treatment in most …
Genomic and metabolic versatility of Pseudomonas aeruginosa contributes to its inter-kingdom transmission and survival
S Ambreetha, D Zincke… - Journal of Medical …, 2024 - microbiologyresearch.org
Pseudomonas aeruginosa is one of the most versatile bacteria with renowned pathogenicity
and extensive drug resistance. The diverse habitats of this bacterium include fresh, saline …
and extensive drug resistance. The diverse habitats of this bacterium include fresh, saline …
The Effect of Cigarette Smoke Extract on the Activity of Clarithromycin with Anti-Pseudomonal Agents on Growth and Biofilm Formation of Pseudomonas Aeruginosa
L Sekalo - 2023 - search.proquest.com
The present study was undertaken with the initial objective of investigating the effects of six
primary anti-pseudomonal antibiotics, namely amikacin, cefepime, ciprofloxacin …
primary anti-pseudomonal antibiotics, namely amikacin, cefepime, ciprofloxacin …
Thoracic Kyphotic Deformity Secondary to Old Pseudomonas aeruginosa Spondylodiscitis in an Immunocompromised Patient With Persistent Infection Foci—A Case …
A Bourghli, L Boissiere, I Obeid - International Journal of Spine …, 2019 - ijssurgery.com
Background: Kyphosis secondary to pyogenic spondylodiscitis is rare and its management
can be very challenging. Methods: In this report, we present the case of a 28-year-old …
can be very challenging. Methods: In this report, we present the case of a 28-year-old …
The isolation of ocean microbes that produce antibiotics against Pseudomonas aeruginosa strains from cystic fibrosis patients
DM Walsh - 2018 - search.proquest.com
f / 2 d J ^ f Z o { £ Page 1 THE ISOLATION OF OCEAN MICROBES THAT PRODUCE
ANTIBIOTICS AGAINST PSEUDOMONAS AERUGINOSA STRAINS FROM CYSTIC …
ANTIBIOTICS AGAINST PSEUDOMONAS AERUGINOSA STRAINS FROM CYSTIC …